Taken together, our data support that FOXP3+ Treg expansion in SLE is a marker of disease activity, likely as a compensatory mechanism to control excess T-cell activity in the context of a recent autoimmune reaction or flare. The gene discussed is FOXP3; the disease is systemic lupus erythematosus.